NO20092770L - Nye aminopyrimidinderivater som PLK1-inhibitorer - Google Patents
Nye aminopyrimidinderivater som PLK1-inhibitorerInfo
- Publication number
- NO20092770L NO20092770L NO20092770A NO20092770A NO20092770L NO 20092770 L NO20092770 L NO 20092770L NO 20092770 A NO20092770 A NO 20092770A NO 20092770 A NO20092770 A NO 20092770A NO 20092770 L NO20092770 L NO 20092770L
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- alkyl group
- group
- substituted
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Den foreliggende oppfinnelse angår en forbindelse representert med formel (I): eller farmasøytisk akseptabelt salt eller ester derav, hvor Ri og R2, som kan være like eller forskjellige, begge er et hydrogenatom, halogenatom, en lavere alkylgruppe som kan være substituert, eller syklopropylgruppe; R3 og R4, som kan være like eller forskjellige, er begge et hydrogenatom, en lavere alkylgruppe substituert med NRaRb, en 4-6-leddet, alifatisk, heterosyklisk gruppe, en lavere alkylgruppe substituert med en 4-6-leddet, alifatisk, heterosyklisk gruppe, en 5-eller 6-leddet, aromatisk, heterosyklisk gruppe, eller en lavere alkylgruppe substituert med en 5- eller 6-leddet, aromatisk, heterosyklisk gruppe; og R5 er et hydrogenatom, en cyanogruppe, et halogenatom eller en lavere alkylgruppe.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006356575 | 2006-12-28 | ||
| JP2007265783 | 2007-10-11 | ||
| PCT/JP2007/075224 WO2008081910A1 (en) | 2006-12-28 | 2007-12-20 | Novel aminopyrimidine derivatives as plk1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20092770L true NO20092770L (no) | 2009-09-25 |
Family
ID=39588592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20092770A NO20092770L (no) | 2006-12-28 | 2009-07-27 | Nye aminopyrimidinderivater som PLK1-inhibitorer |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7977336B2 (no) |
| EP (2) | EP2116543A4 (no) |
| JP (1) | JPWO2008081914A1 (no) |
| KR (1) | KR101481388B1 (no) |
| CN (1) | CN101573361B (no) |
| AR (1) | AR064619A1 (no) |
| AU (1) | AU2007340530B2 (no) |
| BR (1) | BRPI0718966B8 (no) |
| CA (1) | CA2668738A1 (no) |
| CL (1) | CL2007003758A1 (no) |
| CO (1) | CO6190523A2 (no) |
| CR (1) | CR10784A (no) |
| EC (1) | ECSP099324A (no) |
| GT (1) | GT200900124A (no) |
| IL (1) | IL198675A0 (no) |
| MA (1) | MA31109B1 (no) |
| MX (1) | MX2009004920A (no) |
| NO (1) | NO20092770L (no) |
| NZ (1) | NZ577273A (no) |
| PE (1) | PE20081845A1 (no) |
| RU (1) | RU2458062C2 (no) |
| SV (1) | SV2009003258A (no) |
| TW (1) | TW200835485A (no) |
| WO (2) | WO2008081910A1 (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101679408B (zh) | 2006-12-22 | 2016-04-27 | Astex治疗学有限公司 | 作为fgfr抑制剂的双环杂环化合物 |
| JP5442449B2 (ja) | 2006-12-22 | 2014-03-12 | アステックス、セラピューティックス、リミテッド | 新規化合物 |
| GB0720038D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New compounds |
| GB0720041D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New Compounds |
| GB0810902D0 (en) | 2008-06-13 | 2008-07-23 | Astex Therapeutics Ltd | New compounds |
| WO2010013633A1 (ja) * | 2008-07-31 | 2010-02-04 | 萬有製薬株式会社 | 細胞のｒｂステイタス及びｐｌｋ１阻害剤に対する感受性を予測する方法 |
| JP4489132B2 (ja) * | 2008-08-22 | 2010-06-23 | 株式会社東芝 | 磁気記録媒体の製造方法 |
| GB0906470D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
| GB0906472D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
| US8445674B2 (en) | 2009-10-21 | 2013-05-21 | Hoffmann-La Roche Inc | Heterocyclyl compounds |
| PH12012500778A1 (en) | 2009-10-30 | 2012-11-26 | Janssen Pharmaceutica Nv | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
| UY33213A (es) | 2010-02-18 | 2011-09-30 | Almirall Sa | Derivados de pirazol como inhibidores de jak |
| AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
| EP2463289A1 (en) | 2010-11-26 | 2012-06-13 | Almirall, S.A. | Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors |
| JP6115962B2 (ja) | 2011-06-27 | 2017-04-19 | ヤンセン ファーマシューティカ エヌ．ベー． | １−アリール−４−メチル−［１，２，４］トリアゾロ［４，３−ａ］キノキサリン誘導体 |
| EP2554544A1 (en) | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
| MX342326B (es) | 2011-09-27 | 2016-09-26 | Novartis Ag | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante. |
| WO2014001314A1 (en) | 2012-06-26 | 2014-01-03 | Janssen Pharmaceutica Nv | Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders |
| AU2013289284B2 (en) | 2012-07-09 | 2017-03-30 | Janssen Pharmaceutica Nv | Inhibitors of phosphodiesterase 10 enzyme |
| US9921222B2 (en) | 2012-07-31 | 2018-03-20 | Crown Bioscience, Inc. (Taicang) | Histological markers for identifying non-small cell lung carcinoma patients for treatment with an anti-EGFR drug |
| WO2014046617A1 (en) * | 2012-09-19 | 2014-03-27 | Agency For Science, Technology And Research | Compositions and methods for treating cancer |
| EP3194367B1 (en) | 2014-09-17 | 2021-08-18 | Boehringer Ingelheim International GmbH | Tetrahydroisoquinoline derivatives and pharmaceutical compositions useful for the treatment of obesity and diabetes |
| US20230190717A1 (en) * | 2017-04-10 | 2023-06-22 | City Of Hope | P38 gamma inhibitors and method of use thereof |
| CN114269742B (zh) * | 2019-07-10 | 2024-07-16 | 常州千红生化制药股份有限公司 | 作为治疗剂的4-(咪唑并[1,2-a]吡啶-3-基)-N-(吡啶基)嘧啶-2-胺的衍生物 |
| EP4003992A1 (en) * | 2019-07-24 | 2022-06-01 | Merck Patent GmbH | 4-(imidazo[1,2-a]pyridin-3-yl) -pyrimidine derivatives |
| CN112592318B (zh) * | 2020-12-12 | 2022-05-03 | 贵州医科大学 | 2-(4-甲氨酰基)苯胺基-4-氨基嘧啶衍生物及应用 |
| WO2024071401A1 (ja) | 2022-09-29 | 2024-04-04 | 公益財団法人がん研究会 | Ｐｌｋ１キナーゼ活性化による染色体制御破綻が誘導するがん細胞増殖抑制を創薬概念とする医薬のスクリーニング方法 |
| CN119318874B (zh) * | 2024-12-18 | 2025-04-15 | 淄博凯美可工贸有限公司 | 一种节能型复合脱硫剂的制备方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6019790A (ja) | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| US5223608A (en) | 1987-08-28 | 1993-06-29 | Eli Lilly And Company | Process for and intermediates of 2',2'-difluoronucleosides |
| FI95708C (fi) | 1988-10-31 | 1996-03-11 | Eisai Co Ltd | Analogiamenetelmä 1,4-diatsepiinijohdannaisen ja sen farmaseuttisesti sopivan suolan valmistamiseksi |
| JPH045029A (ja) | 1990-04-23 | 1992-01-09 | Bridgestone Corp | 空気入りタイヤ |
| DK0547165T3 (da) | 1990-09-28 | 2000-03-27 | Smithkline Beecham Corp | Fremgangsmåde til fremstilling af vandopløselige camptothecinanaloger såvel som forbindelserne 10-hydroxy-11-C(1-6)-alkoxyc |
| US5243050A (en) | 1990-12-20 | 1993-09-07 | North Carolina State University | Alkylpyridone DE ring intermediates useful for the manufacture of camptothecin and camptothecin analogs |
| US5162532A (en) | 1990-12-20 | 1992-11-10 | North Carolina State University | Intermediates and method of making camptothecin and camptothecin analogs |
| US5191082A (en) | 1990-12-20 | 1993-03-02 | North Carolina State University | Camptothecin intermediate and method of making camptothecin intermediates |
| US5200524A (en) | 1990-12-20 | 1993-04-06 | North Carolina State University | Camptothecin intermediates and method of making same |
| US5247089A (en) | 1990-12-20 | 1993-09-21 | North Carolina State University | Method of making intermediates useful for the manufacture of camptothecin and camptothecin analogs |
| KR100335584B1 (ko) | 1992-10-28 | 2002-11-29 | 제넨테크, 인코포레이티드 | 혈관내피세포성장인자에대한길항제 |
| JP3025602B2 (ja) | 1993-05-21 | 2000-03-27 | デビオファーム エス．アー． | 光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法 |
| GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| CA2222231A1 (en) | 1995-06-07 | 1996-12-19 | Imclone Systems Incorporated | Antibody and antibody fragments for inhibiting the growth of tumors |
| JP3154399B2 (ja) | 1996-07-04 | 2001-04-09 | デビオファーム エス．アー． | 白金化合物の製造方法 |
| US6610697B1 (en) * | 1999-11-10 | 2003-08-26 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods |
| US6703508B2 (en) | 2000-12-04 | 2004-03-09 | Sepracor, Inc. | Methods for the stereoselective synthesis of substituted piperidines |
| CA2450555A1 (en) | 2001-06-25 | 2003-01-03 | Merck & Co., Inc. | (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| CA2455181C (en) | 2001-08-01 | 2010-04-06 | Merck & Co., Inc. | Benzimidazo[4,5-f]isoquinolinone derivatives |
| UA80296C2 (en) | 2002-09-06 | 2007-09-10 | Biogen Inc | Imidazolopyridines and methods of making and using the same |
| WO2004043936A1 (ja) | 2002-11-14 | 2004-05-27 | Kyowa Hakko Kogyo Co., Ltd. | Ｐｌｋ阻害剤 |
| AU2005225471B2 (en) | 2004-03-26 | 2011-05-12 | Methylgene Inc. | Inhibitors of histone deacetylase |
| CA2577947A1 (en) * | 2004-08-31 | 2006-03-09 | Banyu Pharmaceutical Co., Ltd. | Novel substituted imidazole derivative |
-
2007
- 2007-12-18 US US12/002,546 patent/US7977336B2/en active Active
- 2007-12-20 TW TW096149071A patent/TW200835485A/zh unknown
- 2007-12-20 BR BRPI0718966A patent/BRPI0718966B8/pt active IP Right Grant
- 2007-12-20 MX MX2009004920A patent/MX2009004920A/es active IP Right Grant
- 2007-12-20 JP JP2008552168A patent/JPWO2008081914A1/ja not_active Ceased
- 2007-12-20 CL CL200703758A patent/CL2007003758A1/es unknown
- 2007-12-20 NZ NZ577273A patent/NZ577273A/en not_active IP Right Cessation
- 2007-12-20 CA CA002668738A patent/CA2668738A1/en not_active Abandoned
- 2007-12-20 EP EP07851126A patent/EP2116543A4/en not_active Withdrawn
- 2007-12-20 KR KR1020097013324A patent/KR101481388B1/ko active Active
- 2007-12-20 EP EP07851112A patent/EP2114942B1/en active Active
- 2007-12-20 CN CN2007800488795A patent/CN101573361B/zh active Active
- 2007-12-20 AR ARP070105784A patent/AR064619A1/es not_active Application Discontinuation
- 2007-12-20 RU RU2009128966/04A patent/RU2458062C2/ru active
- 2007-12-20 WO PCT/JP2007/075224 patent/WO2008081910A1/en not_active Ceased
- 2007-12-20 AU AU2007340530A patent/AU2007340530B2/en active Active
- 2007-12-20 WO PCT/JP2007/075240 patent/WO2008081914A1/ja not_active Ceased
-
2008
- 2008-01-02 PE PE2008000054A patent/PE20081845A1/es not_active Application Discontinuation
-
2009
- 2009-05-08 CR CR10784A patent/CR10784A/es not_active Application Discontinuation
- 2009-05-10 IL IL198675A patent/IL198675A0/en unknown
- 2009-05-12 GT GT200900124A patent/GT200900124A/es unknown
- 2009-05-12 SV SV2009003258A patent/SV2009003258A/es active IP Right Grant
- 2009-05-12 EC EC2009009324A patent/ECSP099324A/es unknown
- 2009-05-12 CO CO09048000A patent/CO6190523A2/es not_active Application Discontinuation
- 2009-07-23 MA MA32115A patent/MA31109B1/fr unknown
- 2009-07-27 NO NO20092770A patent/NO20092770L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009004920A (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1. | |
| WO2008136444A1 (ja) | 縮合複素環誘導体 | |
| NO20082976L (no) | Svovelholdige cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer | |
| NO20074763L (no) | (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi | |
| WO2009095792A3 (en) | Substituted heteroarylamide diazepinopyrimidone derivatives | |
| NO20092286L (no) | Nitrogenhaldige heterosykliske forbindelser og anvendelse derav | |
| MX2010003445A (es) | Derivados de nicotinamida, su preparacion y su uso terapeutico. | |
| NO331165B1 (no) | Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter | |
| NO20082388L (no) | Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer | |
| MY153393A (en) | Amino nicotinic and isonicotinic acid derivatives as dhodh as inhibitors | |
| NO20081464L (no) | 1-heterocyklusulfonyl, 2-aminometyl, 5-(hetero-)aryl subsidiert 1-H-pyrrol-derivater som syresekresjonsinhibitorer | |
| UA116794C2 (uk) | Моноциклічна піридинова похідна | |
| MX2011009146A (es) | Sales de adicion de aminas que contienen grupos hidroxilo y/o carboxilicos con derivados de acido aminonicotinico como inhibidores de dhodh. | |
| NO20074311L (no) | Kinazolinderivat med tyrosinkinase-inhiberendeaktivitet | |
| WO2008051533A3 (en) | Benzimidazole compounds | |
| MY169179A (en) | Novel piperidine compound or salt thereof | |
| MX2009011769A (es) | Derivados de piridona como inhibidores de mapk p38a. | |
| MX2010008360A (es) | Derivados de oxazepinopirimidona heteroarilamida sustituidos. | |
| WO2008155668A3 (en) | Heteroarylamide pyrimidone compounds | |
| MX2010008361A (es) | Derivados de arilamida oxazepinopirimidona sustituidos. | |
| MX2011011281A (es) | Compuesto de carbinol que tiene un enlazante heterociclico. | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| TW200602028A (en) | Compounds | |
| EA201101298A1 (ru) | Аддитивные соли трометамина с производными азабифениламинобензойной кислоты в качестве ингибиторов dhodh | |
| WO2008155670A3 (en) | Arylamide pyrimidone compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |